-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2014 to Q1 2024.
- Hepion Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $30.8K, a 70.5% increase year-over-year.
- Hepion Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $67.1K, a 13.3% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $77.5K, a 10% decline from 2021.
- Hepion Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $86.1K, a 149% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)